Subscribe
feng
matdesign24 / iStockphoto.com
20 September 2017Americas

CRISPR scientist awarded Lemelson-MIT prize

Feng Zhang, one of the pioneers of CRISPR technology, has been announced as the 2017 recipient of the $500,000 Lemelson-MIT Prize, which honours outstanding inventors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
LSIPR 50 2016: Florence Wambugu and Feng Zhang
5 October 2016   Florence Wambugu and Feng Zhang were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Wambugu and Zhang were featured in the business and innovation section, as LSIPR reports.
Europe
Muddied waters: the CRISPR IP landscape in Europe
18 February 2016   The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF.


Editor's picks

Bankruptcy judge approves $305m sale of genetics testing company
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025

Editor's picks

Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025

More on this story

Africa
LSIPR 50 2016: Florence Wambugu and Feng Zhang
5 October 2016   Florence Wambugu and Feng Zhang were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Wambugu and Zhang were featured in the business and innovation section, as LSIPR reports.
Europe
Muddied waters: the CRISPR IP landscape in Europe
18 February 2016   The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF.

More on this story

Africa
LSIPR 50 2016: Florence Wambugu and Feng Zhang
5 October 2016   Florence Wambugu and Feng Zhang were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Wambugu and Zhang were featured in the business and innovation section, as LSIPR reports.
Europe
Muddied waters: the CRISPR IP landscape in Europe
18 February 2016   The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF.

More features

Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations